ID

34266

Descripción

The Norwegian Pancreas Transplantation (PTx) Study; ODM derived from: https://clinicaltrials.gov/show/NCT01957696

Link

https://clinicaltrials.gov/show/NCT01957696

Palabras clave

  1. 16/1/19 16/1/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

16 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus NCT01957696

Eligibility Diabetes Mellitus NCT01957696

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥18 years
Descripción

ID.1

Tipo de datos

boolean

patients who receive a primary or secondary pancreas transplant, with or without a simultaneous kidney transplant (spk).
Descripción

ID.2

Tipo de datos

boolean

women who are of childbearing potential must have a negative serum pregnancy test at baseline.
Descripción

ID.3

Tipo de datos

boolean

operability has to be ascertained by preoperative examination, performed by nephrologist, transplant surgeon and anaesthesiologist.
Descripción

ID.4

Tipo de datos

boolean

signed and dated informed consent form.
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of systemic infection
Descripción

ID.6

Tipo de datos

boolean

presence of unstable cardiovascular disease.
Descripción

ID.7

Tipo de datos

boolean

malignancy < 5 years prior to entry into the trial (with the exception of adequately treated basal cell or squamous cell carcinomas of the skin).
Descripción

ID.8

Tipo de datos

boolean

panel-reactive antibodies (pra) > 20% or the presence of donor-specific antigens (dsa).
Descripción

ID.9

Tipo de datos

boolean

any positive test for hbv, hbc or hiv.
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Diabetes Mellitus NCT01957696

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age ≥18 years
boolean
ID.2
Item
patients who receive a primary or secondary pancreas transplant, with or without a simultaneous kidney transplant (spk).
boolean
ID.3
Item
women who are of childbearing potential must have a negative serum pregnancy test at baseline.
boolean
ID.4
Item
operability has to be ascertained by preoperative examination, performed by nephrologist, transplant surgeon and anaesthesiologist.
boolean
ID.5
Item
signed and dated informed consent form.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
evidence of systemic infection
boolean
ID.7
Item
presence of unstable cardiovascular disease.
boolean
ID.8
Item
malignancy < 5 years prior to entry into the trial (with the exception of adequately treated basal cell or squamous cell carcinomas of the skin).
boolean
ID.9
Item
panel-reactive antibodies (pra) > 20% or the presence of donor-specific antigens (dsa).
boolean
ID.10
Item
any positive test for hbv, hbc or hiv.
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial